September 2023 Vol 14, No 9
As oncology patient navigation leaders, we knew it before the start of the COVID-19 pandemic. Sadly, the pandemic spotlighted the longstanding health inequities that have existed systemically in the United States and gave impetus to highlight it—the fact that patient navigation is an evidence-based intervention that effectively addresses disparities in cancer care.
CLL’s unique properties may lead to providers and patients conceptualizing the prognosis differently. These findings present new information about the needs of people with CLL, with potentially transferable implications for people with other chronic illnesses. Information should be shared with providers about how to discuss a CLL prognosis sensitively.
Demographics of Individuals Refusing Cancer Treatment and Reported Pain Compared With Those in Treatment: An Analysis of the 2017-2020 Behavioral Risk Factor Surveillance System
More than 1.6 million people are diagnosed with cancer each year. Despite the different treatment options available for cancer, many individuals refuse treatment for various reasons. However, little is known about the cumulative group of individuals who refuse treatment.
Approximately 45% of all Americans suffer from 1 or more chronic diseases, which are among the most prevalent and costly health conditions in the United States.
Cancer, chronic conditions, and comorbidities often lead to polypharmacy. What is it, and what should oncology navigators know about helping their patients manage it?
Results 1 - 6 of 6